Skip to main content
. 2025 Sep 17;13(9):2285. doi: 10.3390/biomedicines13092285
18F-DOPA 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine
ADC Apparent diffusion coefficient
AGI Artificial general intelligence
AI Artificial intelligence
ANN Artificial neural network
APOLLO Raman-based pathology of malignant glioma
AR Augmented reality
ATRX Alpha-thalassemia/mental retardation X-linked
AUC Area under curve
AURORA A multicenter analysis of stereotactic radiotherapy to the resection cavity of brain metastases
BBB Blood-brain barrier
BCRP Breast cancer resistance protein
BraTumIA Brain tumor image analysis
CAR Chimeric antigen receptor
CBF Cerebral blood flow
CDKN2A/B Cyclin-dependent kinase inhibitor 2A/B
CET Contrast-enhancing tumor
CFD Cell fate determinant
Cho Choline
CIC Capicua transcriptional repressor
CMRO2 Cerebral metabolic rate of oxygen
CNN Convolutional neural network
CNS Central nervous system
CPH Cox proportional hazards
Cr Creatine
CT Computed tomography
CTL Cytotoxic T-lymphocyte
CTV Clinical target volume
DL Deep learning
DSC Dice similarity coefficient
DSC Dynamic susceptibility contrast
DTI Diffusion-tensor imaging
DWI Diffusion-weighted imaging
EGFR Epidermal growth factor receptor
FDG 18F-fluorodeoxyglucose
FLAIR Fluid-attenuated inversion recovery
FPR3 N-formyl peptide receptor 3
GBM Glioblastoma multiforme
G-CIMP Cytosine-phosphate-guanine island methylator phenotype
GPT-3 Generative pre-trained transformer 3
Grad-CAM Gradient-weighted class activation mapping
GRS Glycolysis-related gene signature
GTV Gross tumor volume
HDFT-F High-definition fiber tractography with sodium fluorescein
HSI Hyperspectral imaging
HUD Head-up display
IBM International Business Machines Corporation
ICI Immune checkpoint inhibitor
iDC-APC Induced antigen-presenting cells
IDH1 Isocitrate dehydrogenase 1
IL-6 Interleukin 6
IM Immune subtype
IMRT Intensity-modulated radiation therapy
KPS Karnofsky performance status
kVCT Kilovoltage computed tomography
Lac Lactate
LF Local failure
LORIS Logistic regression-based immunotherapy-response score
LSTM Long short-term memory
mAR Mobile augmented reality
MGMT O[6]-methylguanine-DNA methyltransferase
MIL Multi-instance learning
mitoPO2 Tissue oxygen saturation
ML Machine learning
MR Mixed reality
MRI Magnetic resonance imaging
MRPM Magnetic resonance projection mapping
MRS Magnetic resonance spectroscopy
NAA N-acetylaspartate
NET2 Non-enhancing T2 hyperintense
NK Natural killer
NLP Natural language processing
NLU Natural language understanding
OEF Oxygen extraction fraction
OS Overall survival
PCNSL Primary central nervous system lymphoma
PD1 Programmed cell death protein 1
PET Positron emission tomography
PFS Progression-free survival
P-gp P-glycoprotein
RANO Response assessment in neuro-oncology
rCBV Relative cerebral blood volume
ROC Receiver operating characteristic
ROI Region of interest
RSF Random survival forest
RS-fMRI Resting-state functional magnetic resonance imaging
SHAP Shapley additive explanations
SINA Sina intraoperative neurosurgical assist
SRMA Systematic review and meta-analysis
SRT Stereotactic radiation therapy
SVM Support vector machine
T1GD T1-weighted gadolinium-enhanced
TCGA The Cancer Genome Atlas
TCIA The Cancer Imaging Archive
TERT Telomerase reverse transcriptase
TERTp Telomerase reverse transcriptase gene promoter
TME Tumor microenvironment
TMZ Temozolomide
TP53 Tumor protein 53
TRIPOD Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis
TVN Trans-visible navigator
ViT Vision transformer
VNIR Visible and near-infrared
VR Virtual reality
WHO World Health Organization
WSI Whole-slide image
WSL Weakly supervised learning
XAI Explainable artificial intelligence